Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Historical Epidemiology of Hepatitis C Virus (Hcv) in Select Countries - Volume 3 Publisher Pubmed



Liakina V1, 2 ; Hamid S3 ; Tanaka J4 ; Olafsson S5 ; Sharara AI6 ; Alavian SM7, 8 ; Gheorghe L9 ; El Hassan ES10 ; Abaalkhail F11 ; Abbas Z12 ; Abdou A10 ; Abourached A13 ; Al Braiki F14 ; Al Hosani F15 Show All Authors
Authors
  1. Liakina V1, 2
  2. Hamid S3
  3. Tanaka J4
  4. Olafsson S5
  5. Sharara AI6
  6. Alavian SM7, 8
  7. Gheorghe L9
  8. El Hassan ES10
  9. Abaalkhail F11
  10. Abbas Z12
  11. Abdou A10
  12. Abourached A13
  13. Al Braiki F14
  14. Al Hosani F15
  15. Al Jaberi K16
  16. Al Khatry M17
  17. Al Mulla MA15
  18. Al Quraishi H18
  19. Al Rifai A19
  20. Al Serkal Y20
  21. Alam A21
  22. Alashgar HI22
  23. Alawadhi S10
  24. Aldabal L23
  25. Aldins P24
  26. Alfaleh FZ25
  27. Alghamdi AS26
  28. Alhakeem R27
  29. Aljumah AA28
  30. Almessabi A14
  31. Alqutub AN26
  32. Alswat KA29
  33. Altraif I28
  34. Alzaabi M30
  35. Andrea N31
  36. Assiri AM27
  37. Babatin MA26
  38. Baqir A32
  39. Barakat MT33
  40. Bergmann OM5
  41. Bizri AR34
  42. Blach S35
  43. Chaudhry A36
  44. Choi MS37
  45. Diab T38
  46. Djauzi S39
  47. El Khoury S40
  48. Estes C35
  49. Fakhry S41
  50. Farooqi JI42, 43, 44
  51. Fridjonsdottir H44
  52. Gani RA39
  53. Ghafoor Khan A45
  54. Goldis A46
  55. Gottfredsson M47
  56. Gregorcic S48
  57. Hajarizadeh B49
  58. Han KH50, 51
  59. Hasan I39
  60. Hashim A52
  61. Horvath G53
  62. Hunyady B54, 55
  63. Husni R56
  64. Jafri W57
  65. Jeruma A58, 59, 60
  66. Jonasson JG45, 61, 62
  67. Karlsdottir B62
  68. Kim DY51
  69. Kim YS63
  70. Koutoubi Z64, 65
  71. Lesmana LA39, 40, 66
  72. Lim YS66, 67
  73. Love A47, 48, 68
  74. Maimets M68
  75. Makara M69
  76. Malekzadeh R70
  77. Maticic M48
  78. Memon MS71
  79. Merat S70
  80. Mokhbat JE72
  81. Mourad FH6
  82. Muljono DH73, 74, 75
  83. Nawaz A75
  84. Nugrahini N76
  85. Priohutomo S77
  86. Qureshi H78
  87. Rassam P40
  88. Razavi H35
  89. Razavishearer D35
  90. Razavishearer K35
  91. Rozentale B58, 59, 60
  92. Sadik M71
  93. Saeed K79
  94. Salamat A80
  95. Salupere R68
  96. Sanai FM25
  97. Sanityoso Sulaiman A39
  98. Sayegh RA81
  99. Schmelzer JD35
  100. Sibley A35
  101. Siddiq M82, 83, 84
  102. Siddiqui AM84
  103. Sigmundsdottir G85, 86
  104. Sigurdardottir B62
  105. Speiciene D1
  106. Sulaiman A39, 40, 87
  107. Sultan MA87
  108. Taha M88
  109. Tarifi H89
  110. Tayyab G90, 91, 92
  111. Tolmane I58
  112. Ud Din M92
  113. Umar M93, 94, 95
  114. Valantinas J1
  115. Videcnikzorman J48, 49
  116. Yaghi C81, 82
  117. Yunihastuti E95
  118. Yusuf MA96
  119. Zuberi BF97
  120. Gunter J35, 36

Source: Journal of Viral Hepatitis Published:2015


Abstract

Detailed, country-specific epidemiological data are needed to characterize the burden of chronic hepatitis C virus (HCV) infection around the world. With new treatment options available, policy makers and public health officials must reconsider national strategies for infection control. In this study of 15 countries, published and unpublished data on HCV prevalence, viraemia, genotype, age and gender distribution, liver transplants and diagnosis and treatment rates were gathered from the literature and validated by expert consensus in each country. Viraemic prevalence in this study ranged from 0.2% in Iran and Lebanon to 4.2% in Pakistan. The largest viraemic populations were in Pakistan (7 001 000 cases) and Indonesia (3 187 000 cases). Injection drug use (IDU) and a historically unsafe blood supply were major risk factors in most countries. Diagnosis, treatment and liver transplant rates varied widely between countries. However, comparison across countries was difficult as the number of cases changes over time. Access to reliable data on measures such as these is critical for the development of future strategies to manage the disease burden. © 2015 John Wiley & Sons Ltd.
Other Related Docs
13. Hepatocellular Cancer in Iran, Liver Cancer in the Middle East (2021)